rs10905656

Positions:

• chr10-6044130-C-A
• chr10-6044130-C-G
• chr10-6044130-C-T

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_000417.3(IL2RA):​c.64+17958G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.393 in 152,096 control chromosomes in the GnomAD database, including 12,877 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.39 (12877 hom., cov: 33)
• Consequence: IL2RA NM_000417.3 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 0.565

Genes affected

IL2RA (HGNC:6008): (interleukin 2 receptor subunit alpha) The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolyisis. Alternately-spliced IL2RA mRNAs have been isolated, but the significance of each is presently unknown. Mutations in this gene are associated with interleukin 2 receptor alpha deficiency. Patients with severe Coronavirus Disease 2019 (COVID-19), the disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have significantly elevated levels of IL2R in their plasma. Similarly, serum IL-2R levels are found to be elevated in patients with different types of carcinomas. Certain IL2RA and IL2RB gene polymorphisms have been associated with lung cancer risk. [provided by RefSeq, Jul 2020]

IL2RA (HGNC:):

ACMG classification

Verdict is Benign. Variant got -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.83).
• BA1: GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.592 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
IL2RA	NM_000417.3	c.64+17958G>T		intron_variant		ENST00000379959.8	NP_000408.1
IL2RA	NM_001308242.2	c.64+17958G>T		intron_variant			NP_001295171.1
IL2RA	NM_001308243.2	c.64+17958G>T		intron_variant			NP_001295172.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
IL2RA	ENST00000379959.8	c.64+17958G>T		intron_variant		1	NM_000417.3	ENSP00000369293.3

Frequencies

GnomAD3 genomes AF: 0.393 AC: 59665 AN: 151978 Hom.: 12859 Cov.: 33

Gnomad AFR AF: 0.231

Gnomad AMI AF: 0.310

Gnomad AMR AF: 0.552

Gnomad ASJ AF: 0.456

Gnomad EAS AF: 0.609

Gnomad SAS AF: 0.425

Gnomad FIN AF: 0.516

Gnomad MID AF: 0.392

Gnomad NFE AF: 0.414

Gnomad OTH AF: 0.419

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.393 AC: 59710 AN: 152096 Hom.: 12877 Cov.: 33 AF XY: 0.402 AC XY: 29914 AN XY: 74352

Gnomad4 AFR AF: 0.231

Gnomad4 AMR AF: 0.552

Gnomad4 ASJ AF: 0.456

Gnomad4 EAS AF: 0.610

Gnomad4 SAS AF: 0.423

Gnomad4 FIN AF: 0.516

Gnomad4 NFE AF: 0.414

Gnomad4 OTH AF: 0.418

Alfa AF: 0.414 Hom.: 13849

Bravo AF: 0.395

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.83
CADD	Benign	6.1
DANN	Benign	0.76

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs10905656; hg19: chr10-6086093;